Wednesday, August 27, 2008

Timothy Tyson to lead Aptuit

By Mass High Tech Staff

Aptuit Inc., a Greenwich, Conn.-based drug-development services firm, has appointed Timothy C. Tyson as executive chairman and acting CEO, company officials said. Tyson replaces Aptuit founder and former CEO Michael A. Griffith, who resigned to pursue other opportunities.

Tyson has previously held COO, president and CEO positions at Valeant Pharmaceuticals International; role of president of global manufacturing and supply at GlaxoSmithKline, in charge of Glaxo Dermatology and Cerenex Pharmaceuticals; and several executive positions in commercial, technical and research and development positions at Bristol-Myers.

Apuit provides drug development services to more than 800 biotechnology and pharmaceutical companies globally. The company reports a partnership with private equity investors Welsh, Carson, Anderson & Stow.

In September 2007, Aptuit announced it had acquired the chemical and pharmaceutical development business of German firm Evotec AG for $63.9 million. Prior to that, Aptuit spent several years acquiring various companies, including EaglePicher Pharmaceutical Services LLC, SSCI Inc., InfoPro Solutions, Almedica International and three business units of Quintiles Transnational.